関連する実験動画
Updated: May 2, 2026

06:33
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
7.2K
システミックな心臓アミロイドーゼ: 3つの主要なタイプの疾患プロファイルと臨床経過
Claudio Rapezzi1, Giampaolo Merlini, Candida C Quarta
1Istituto di Cardiologia, Policlinico S. Orsola-Malpighi, Via Massarenti n 9, 40125 Bologna, Italy. claudio.rapezzi@unibo.it
Circulation
|September 16, 2009
まとめ
既得軽鎖性 (AL),遺伝性変異性トランスチレチン (ATTRm),野生型トランスチレチン (ATTRwt) アミロイドーシスは,異なる心臓疾患である. これらの違いを理解することは,正確な診断と患者の管理に不可欠です.
科学分野:
- 心臓病学 心臓病学
- 内科内科は,内科の内科である.
- 遺伝学 遺伝学とは
背景:
- 心臓アミロイドーシスは,しばしば単一の実体として研究され,獲得された軽鎖 (AL),遺伝的変異型トランスチレチン関連 (ATTRm),および野生型トランスチレチン関連 (ATTRwt) タイプを含む.
- この3種類の全身性心筋アミロイドーシスには,根本的な病理と臨床的な表現が異なっている.
研究 の 目的:
- AL,ATTRm,ATTRwtの診断および臨床プロフィールを比較するために,心筋アミロイドーシス.
- 正確な分類,診断,管理のためにこれらのサブタイプを区別することの重要性を強調します.
主な方法:
- 確認された心臓アミロイドーシス診断 (AL,ATTRm,ATTRwt) を受けた233人の患者を対象に長期的研究が行われました.
- アミロイドーシスの診断と管理を専門とするイタリアの2つのセンターのデータを分析した.
主要な成果:
- ATTRwt患者は主に高齢の男性であり,AL患者はATTRm患者よりも平均年齢が高く診断されました.
- ATTRwtは左心室の壁の厚さを示し,ATTRm患者はQRSの低電圧が頻度が少なく,生存の予測が良くなった.
- AL患者はより顕著な血動力学的障害を示したが,ATTRwtは主要な心臓イベントからの自由を予測した.
結論:
- 既得軽鎖性 (AL),遺伝性変異性トランスチレチン (ATTRm),野生型トランスチレチン (ATTRwt) のアミロイドーシスは,異なる心臓疾患を表しています.
- 心臓アミロイドーシスの異質性を認識することは,疾患の分類,診断,および臨床管理に不可欠です.
- 異なる病理生理学的基底と臨床経過により,各タイプの心臓アミロイドーシスに合わせたアプローチが必要になります.
関連する概念動画
Myocarditis II: Clinical Features and Diagnostic Tests
493
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
493
Myocarditis III: Medical Management
343
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
343
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
943
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Cardiomyopathy I: Introduction and Classification
826
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805

